Clinical trial
Evaluation of Baroreflex Activation Therapy in Patients With Advanced Heart Failure
NCT03230643 is registered in ClinicalTrials.gov with Heart and Diabetes Center North-Rhine Westfalia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Baroreflex Activation Therapy in Patients With Advanced Heart Failure
- Lead sponsor
- Heart and Diabetes Center North-Rhine Westfalia
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 1, 2017
- Completion date
- May 31, 2020
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.